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INTRODUCTION:
The purpose of this study was to investigate the hypothesis that reduced
joint/muscle activity (hypo kinesia) as well as reduced or null loading of limbs (ady-
namia) in gravity would result in reduced decompression-induced gas phase and
symptoms of decompression sickness (DCS). Finding a correlation between the two
phenomena would correspond to the proposed reduction in tissue gas phase formation
in astronauts undergoing decompression during extravehicular acvitity (EVA) in micro-
gravity. The observation may further explain the reported low incidence of DCS in
space.
BACKGROUND:
Operationally important medical challenges of manned space flight include mi-
crogravity-induced cardiovascular deconditioning, total body calcium loss, and the risk
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of decompression sickness (DCS) during extravehicular activity (EVA). Altitude DCS
deserves particular attention because it is a preventable complication, but one that can
have serious consequences if left unattended (53). Evaluation of the interaction be-
tween microgravity exposure and decompression illness is appropriate in view of plans
for extended duration missions and an overall increase in the number of EVAs required
for construction of the space station. It is intended that such investigation will lead to a
better understanding of the interplay between DCS and the human cardiovascular sys-
tem in a microgravity environment.
Decompression sickness results from the formation and growth of gas bubbles
within the tissues and venous blood, e.g., venous air emboli (VAE). Associated symp-
toms can range from mild skin itching or simple joint pain to central nervous system in-
volvement and even cardiovascular collapse. The pathophysiology of DCS may also
impact the lungs as the venous bubbles obstruct the pulmonary microcirculation (13,18)
decreasing cardiac output (CO), increasing pulmonary vascular pressures and altering
lung fluid balance. The preponderance of actual symptoms, however, involve limb pain
that are presumably caused by extravascular bubbles.
Animal models have offered numerous insights into the mechanisms and etiolo-
gies of the symptoms of DCS. The smaller animal models usually require more extreme
decompression exposures before more typical symptoms are manifested. These
symptoms may also be far more severe than occurs routinely in the human clinical
situation, especially where actual mortality rates are reported. The rat, for example, is a
model commonly used in experimental DCS, but often requires greater extremes in de-
compression protocols (6,40,51). As a result, the more subtle effects of DCS are often
overshadowed by the onset of a severe circulatory or pulmonary complications. Large
animals such as the goat and sheep have been useful in evaluating the effects of de-
compression profiles in terms of limb pain (3,8,38) or respiratory complications (3),
whereas the dog and swine have been used for hemodynamic assessment (7,17,58).
Flynn and Lambertsen (27) reported on a number of animal models of log-log relation-
ship between body weight and the nitrogen dose required to produce DCS.
Of equal importance in drawing conclusions from one species or measurement
to another is the type and accuracy of symptom or measurement being made. The pur-
pose of the present study was to examine the effects of moderate decompression stress
in terms of cardiovascular function and pulmonary responses in chronically, instru-
mented, conscious rats using a profile that was well below a threshold of significant
mortality.
The adaptation of the cardiovascular system to the microgravity environment
(cardiovascular deconditioning) appears to be due in part to a cephalad fluid shift and
has been extensively studied in the conscious rat (45). Astronaut EVAs have brought
into question the potential relationship between cardiovascular deconditioning and hy-
pobaric DCS. Compared with careful ground-based studies conducted in hypobaric
chambers, there is a lower incidence of DCS in space during the astronaut EVAs that
would be predicted (52). These studies have established the predicted incidence of
DCS expected, both in relation to the final altitude following a direct or staged decom-
pression and, subsequent to washout of tissue inert gas (e.g. nitrogen) by oxygen pre-
breathing prior to decompression (26). In addition, other factors such as exercise, am-
bulation, time at altitude and individual susceptibility have been examined (2). The in-
teraction between hypobaric decompression and the deconditioned cardiovascular
system has not been previously evaluated. The purpose of this study was to assess
pulmonary and hemodynamic effects of simulated microgravity and hypobaric decom-
pression illness in the conscious rat.
METHODOLOGY:
Principle. Two series of studies were conducted. The first was to evaluate the
cardiopulmonary changes with moderate decompression in rats. The second was to
study the effects of tail-suspension cardiovascular deconditioning and venous air embo-
4lism in simulated microgravity in the rat. The combined procedures of chronic instru-
mentation, tail-suspension deconditioning and decompression were found to compro-
mise overall evaluation. Therefore, the procedures were separated such that instru-
mentation and decompression were evaluated in one series and instrumention, tail-
suspension and venous air infusion (simulating both microgravity deconditioning and
decompression sickness) in the second series.
Overview: All experiments and procedures were approved by the Institutional
Animal Care and Use Committee at The University of Texas Medical School at Houston.
Sprague-Dawley rats were used to study the cardiac function and pulmonary changes
with decompression. In the first series of studies, the rats were divided into two groups,
one using chronically instrumented, awake rats for cardiovascular function assessment
and the second using non-instrumented rats for pulmonary measurements. The pulmo-
nary group was subdivided into groups 2-4 (2 controls, 3 those monitored 0 min post
decompression, and 4 those monitored 60 min post decompression). In the second se-
ries, six groups of rats were studied. Groups 1 and 2 were used to assess the hemody-
namic effects of tail-suspension with and without venous air infusion, whereas groups 3-
6 were used for biochemical analysis. Each animal served as its own control.
I. Cardiovascular Function
a) Instrumentation: The rats were anesthetized with halothane, intubated and
ventilated under isothermic conditions. A left parasternal thoracotomy was performed
and the pericardium exposed and sectioned. A 20-MHZ pulsed Doppler flow probe was
then placed around the ascending aorta for cardiac output measurement. The dis-
placement probe used to measure left ventricular wall thickening was sutured to the left
ventricular wall and an 18 gauge thoracic drain was positioned until closure of the tho-
rax.
The ultrasonic flow probe leads were tunneled to the dorsum of the neck for ex-
ternalization and the surgical wounds closed. Polyvinyl catheters were placed into the
abdominal aorta via the femoral artery and the jugular vein for measurement of arterial
blood pressure and central venous pressure. The catheters were also tunneled to the
neck dorsum. The lungs were reinflated under vacuum and the wounds were infiltrated
with bupivacaine (0.5%) for post-operative analgesia. Antibiotic therapy (gentamycin 5
mg/kg IM) was initiated for a minimum of 5 days. The animals were weighed daily and
inspected for signs of infection.
The single-crystal pulsed Doppler technique for measurement of changes in
myocardial wall thickening fraction has previously been described in detail (34). The
displacement modules operated at a pulse repetition frequency of 8 KHz and an ultra-
sonic frequency of 20 MHZ. The pulsed Doppler system measured displacement of
myocardial tissue through a sample volume with the use of a single crystal which alter-
nately serves as transmitter and receiver. Briefly, it operates by integrating the velocity
of the various myocardial layers that pass back and forth through a range-gated sample
volume located within the myocardium at a fixed distance from the epicardial surface
where the crystal is attached to the myocardial wall. Thickening fraction is defined as
the maximum excursion recorded during systole, divided by the sample volume depth.
The range was set a 2-3 mm depth near the endocardium.
The pulsed Doppler system for measurement of cardiac output in small animals
has also been described in detail (35). Briefly, a linear relationship between true vol-
ume flow and Doppler frequency shift has previously been demonstrated in a variety of
blood vessels with diameters ranging from 1 to 11 mm. At a pulsed repetition frequency
(PRF) of 125 KHz, the Doppler system resolves frequency shifts of up to 62.5 KHz
(PRF/R) at a maximum range (R) from 0.6 to 6 mm and a spatial range of 0.3 mm. True
blood flow was calculated from the maximum Doppler frequency shift using the standard
relationship described by Ishida et al. (37). The Doppler flow probes were manufac-
tured according to previously described techniques (34,35).
b) Hemodynamic Measurements: All hemodynamic variables [e.g. heart rate
(HR), mean arterial (MAP) and central venous pressure (CVP), left ventricular wall
thickening (WT), and cardiac output (CO)] were processed with the multichannel pulsed
Doppler flow/dimension system and were continuously displayed on a Gould physiog-
raph. The wall thickening fraction (TF%) was calculated as 100 x SE/R (SE, the systolic
excursion and R, the range-gate depth). Systemic vascular resistance (SVR) was cal-
culated as MAP/CO.
c) Pulmonary Edema Measurement. The amount of blood-free extravascular
fluid (edema) formation was measured using a modified method of Pearce (48) to ac-
count for the residual blood volume in the organ. The extravascular lung water (EVLW)
was expressed as the extravascular fluid to dry weight ratio.
d) Lung Compliance: For quasi-static lung compliance measurement, the lungs
were isolated, degassed under vacuum (56), placed in a heated humidified chamber
and connected via a tracheal catheter to an infusion/withdrawal pump and an airway
pressure transducer. The lungs were inflated to 30 cm H20 at a rate of 20 ml/min,
equilibrated for 15 min while maintaining 30 cm H20 pressure. Inflation/deflation pres-
sure-volume curves were then collected. The compliance measurements were taken
from the deflation limb of the curve between 30% and 70% of total lung capacity.
e) Bronchoalveolar Lavage (BAL): The trachea was cannulated and the airways
were lavaged with 10 ml cold normal saline (5°c). This procedure was repeated 6 times
for a total lavage volume of 60 ml. The BAL samples were pooled. Total BAL protein
was assayed using the Lowry method with modification for the presence of lipid from the
60 ml pooled lavage (39). BAL hemoglobin levels were measured using a modified
benzidine assay.
f) Cell Counts: Total white cell counts were performed on BAL, pulmonary and
arterial blood and pleural fluid using a Neubauer hemocytometer with EDTA stabiliza-
tion. Differential cell counts were performed with microscopic survey using Wright-
Geimsa stain.
Data Analysis: Data were analyzed using ANOVA with Dunnett's correction for
the individual comparisons in the biochemistry studies. The cardiovascular data were
analyzed using a 2-way ANOVA. Individual comparisons were analyzed using Stu-
dent's t-test with Bonferroni correction. Significance was considered at p<0.05.
Procedure (Decompression Studies): The conscious rats were placed in a rodent re-
straint apparatus and acclimated to the chamber environment before collection of base-
line data. The chamber was then compressed to 616 kPa at 34 kPa/min for a bottom
time of 120 min, then decompressed to sea level at 38 kPa/min. Hemodynamic moni-
toring continued throughout the compression/decompression procedure and for 120 min
after. The chamber environment was maintained at room temperature (+_4°C) during
both compression and decompression with a constant fresh air flow.
Pulmonary measurements (Groups 2-4, n = 60)
Group 2 rats (440+59 g) consisted of non-decompressed controls, group 3 rats
(421_+57 g) were decompressed and measurements taken immediately after the de-
compression (0 min post decompression), and group 4 rats (406+27 g) were decom-
pressed and measurements taken 60 min post decompression. At 0 to 60 min post de-
compression, the rats were anesthetized (pentobarbital sodium, 50 i.p.) and an arterial
blood sample was collected anaerobically from the abdominal aorta for blood gas,
plasma protein, and white blood cell analysis. Pulmonary artery blood samples were
collected by direct puncture of the pulmonary artery following thoracotomy. The animals
were then exsanguinated, pleural fluid collected, and the lungs removed for measure-
ment of compliance, bronchoalveolar lavage (BAL) collection, and extravascular lung
water (pulmonary edema ) measurement. Not all measurements were obtainable from
each rat. The number of rats/measurement are listed in the tables.
Procedure (Tail-Suspension (TS) VAE Studies): Group 1, (n=8) designated VAE, was
exposed to 3 hrs of venous air infusion. We elected to use VAE given as a continuous
infusion to simulate the prolonged bubbling that is reported with hypobaric decompres-
sion exposures used to simulate an astronaut (EVA). In these cases, VAE are detected
with Doppler ultrasound probes for periods lasting several hours during the period of
decompression. Injecting venous gas very slowly in the rat simulated that particular
feature of decompression effects. Although this technique is well established for a
number of species (38), little data is available for the rat. After hemodynamic parame-
ters stabilized, rats received the venous air infusions into the central venous catheter at
a rate of 0.015 ml.kgl.min 1 for 180 min. Cardiovascular data were recorded at 15, 30,
45, 60, 120 and 180 minutes during venous air infusion and at 15, 30, 45 and 120 min-
utes and 24 hrs post infusion.
Group 2 (n=8) designated TS-VAE, experienced cardiovascular deconditioning
by tail- suspension (TS) with a 30 ° head-down tilt. The tail suspension model has pre-
viously been described in detail (44) and is widely used by investigators to simulate the
fluid shifts commonly observed upon exposure to microgravity. Briefly, rats were fitted
with a flexible foam-tape cast applied to the proximal half of the tail. The cast was at-
tached to a swivel and the rats were suspended in a 30 ° head-down tilt. This apparatus
allowed the rats to rotate in a 360 ° arc using their forelimbs and permitted free access to
food and water in a light/dark cycled environment. Following 96 hrs tail-suspension and
while maintained in the suspended position, the animals were infused with venous air
for 3 hrs as described above.
Pulmonary Measurements (Groups 3-6)
Group 3 consisted of normoactive controls, Group 4, tail-suspension only, Group
5, VAE only and Group 6, tail-suspension-VAE. The rats in groups 5 and 6 received
9venous air infusions, as described above. Immediately post infusion, the animals were
anesthetized with pentobarbital sodium (50 mg IP). An arterial blood sample was col-
lected anaerobically for blood gas and plasma protein analysis. The animals were
euthanized by exsanguination and the lungs were removed for the following measure-
ments.
RESULTS
I. Decompression Studies
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The decompression profile used in this study was selected to produce saturation
conditions with moderate bubbling and symptoms. Venous bubbles were visually ob-
served in 90% of the rats examined immediately following decompression (Group 3),
while only 3% (2/60) demonstrated gross symptoms of DCI (hindlimb paralysis, severe
respiratory complications, etc.). Doppler bubble detection in the instrumented rats
(Group 4) was less conclusive, demonstrating bubbles in 37% (7/19) in rats in which the
probe functioned properly. The insensitivity of the Doppler data may be attributable to
the placement of the probe on the right ventricular wall versus the more common pre-
cordial site where effective sampling of all venous blood is more assured. Quantitation
of the bubbles in terms of size or count was not undertaken in these studies.
a. Blood Gas Measurements: (Table 1) Arterial PO2 values were decreased in
Group 3 rats (nonsignificant) and elevated in Group 4 (significant). PaCO2 values were
significantly increased (44.9 + 2.4 mmHg to 51_+ 1.8 mmHg) in Group 3 (p < 0.05) and
were unchanged in Group 4. Increased respiratory frequency with decreased tidal vol-
umes were observed visually in 68% of the rats 0 min. post decompression. These rats
had PaCO2 values significantly higher (53 _+ 8 mmHg) than those without respiratory
symptoms (47 + 1lmmHg) or from the control Group (44.9 + 2.4 mmHg).
b. Pulmonary Measurements: (Table 2) BAL hemoglobin values were increased
in Groups 3 and 4 by 7.5 and (p<0.05) 17 fold, respectively.
creased in Groups 3 and 4 (36% and 77%; Group 4, p < 0.05).
protein ratio was also significantly increased in Group 4 compared to controls.
BAL total protein was in-
The BAL protein/plasma
Plasma
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protein levels were unchanged. Pleural protein and Hb values were unchanged. Lung
compliance was decreased by 10% in Group 3 and 16% in Group 4 (non significant).
c. Cell Counts: Pulmonary blood white cell counts (WBC) were increased in
Group 4 (Figure 1, Bottom). The percentage of arterial and pulmonary WBC that were
neutrophils was slightly elevated (nonsignificant) in both groups (Figure 1, Top). Pleural
fluid WBC was decreased in Group 3, a dilutional effect, while the percentage of neu-
trophils was increased in Group 4 (p < 0.05). BAL WBC increased significantly in both
Groups 3 and 4 (121% and 212%, respectively), as did the percentage of neutrophils in
Group 4 (Figure 1, Top).
d. Pulmonary Edema Measurement: Extravascular lung water (wet/dry
weight ratio) was significantly elevated in Group 4, 60 min. post decompression (Table
2). Cut lung surfaces often revealed perivascular cuffs of edema fluid, especially
around larger vessels. Excess airway fluid was not observed.
e. Cardiovascular Measurements: (Figure 2) Mean arterial blood pressure was
significantly elevated at the end of the compression period and unchanged post de-
compression. Heart rate was unchanged throughout the compression/decompression
protocol. Cardiac output (Figure 3) was unchanged throughout the compression pe-
riod, decreased upon return to sea level pressure (21%, p < 0.05) and remained de-
creased for 60 min. post decompression (21%, p < 0.05). Comparable changes oc-
curred with stroke volume, with a greater degree of recovery, however (18% from
baseline) 120 min. post decompression. Systemic vascular resistance (Figure 2) was
unchanged during the period of compression, increased significantly 0 min. and 60
min. post decompression (65% and 70%) and remained elevated for 120 min. (34%).
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Left ventricular wall thickening fraction (TF) was unchanged for all groups, while right
ventricular TF (Figure 3) was decreased significantly 0 min. and 60 min. post decom-
pression.
I1. Tail-Suspension Studies
Cardiovascular Measurements: In the TS-VAE group, SVR increased signifi-
cantly by 28% from the onset of tail-suspension and remained elevated throughout the
venous air infusion (Figure 4). In the VAE group, SVR increased significantly by 23%
above baseline within 60 min of venous air infusion and remained elevated for 5 hrs.
SVR in the VAE group returned to baseline within 6 hrs. CVP remained unchanged in
both groups.
Cardiac output in the VAE group decreased by 26% by the end of the 180 min
venous air infusion (Figure 4). This was significantly greater than the TS-VAE group
whose CO decreased by 9%. In the TS-VAE group however, tail suspension alone
caused a 11% decrease (non-significant) in CO prior to the venous air infusion. De-
creases in CO from baseline were significant at 1, 2 and 3 hours of venous air infusion
for both TS-VAE and VAE groups, versus control. CO returned to baseline within 3 hrs.
after venous air infusion. Arterial blood pressure was not significantly altered by either
the tail-suspension or VAE. WT remained unchanged in response to tail-suspension or
venous air infusion..
TS-VAE and VAE rats showed a similar response in heart rate to venous air infu-
sion. HR decreased significantly by the first hour of air infusion and remained de-
creased until the end of the infusion. The differences between the two groups were not
significant. In both groups, HR returned to baseline within 6 hrs. (Figure 5).
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Pulmonary Measurements: In the VAE group, lung wet to dry ratio was in-
creased significantly as compared to the three other groups. TS-VAE rats also showed
a significant increase in lung wet to dry ratio as compared to the control group. Tail
suspension alone did not cause a significant increase in extravascular lung water. Arte-
rial blood gas values, pH, PaCO2 and PaO2 were not different from control value in any
experimental group, although the decrease in PaO2 and the increase in PaCO2 seen in
the VAE and TS-VAE groups were consistent with the pathologic pulmonary changes
reported with DCI. Pulmonary compliance was unchanged in all experimental groups
(Table 3).
Total arterial white blood cell counts (WBC) were unchanged in all experimental
groups (Table 4, top). Pulmonary arterial blood white cell counts were significantly in-
creased however, in the VAE group versus controls, but neither the TS or the TS-VAE
groups showed significant differences from the control group. Pleural fluid white blood
cell count was decreased in the VAE group versus the controls. This appeared to be a
dilutional effect due to an increase in pleural fluid volume. BAL WBC counts were un-
changed. Arterial blood neutrophil counts in both the TS-VAE and the VAE groups were
significantly increased over control. Pulmonary and systemic arterial neutrophil counts
were significantly increased in both the VAE and the TS-VAE groups versus the control
group (Table 4). Pleural fluid neutrophil counts were increased significantly in all ex-
perimental groups versus the control.
Pleural fluid protein concentration was increased in the VAE group versus the
controls, but there was no significant change in either the TS or the TS-VAE groups.
Plasma protein levels were unchanged (Table 4, bottom).
in both TS-VAE and in VAE rats (Table 4).
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BAL protein was unchanged
DISCUSSION
I. Decompression Studies
The data reported in this study further demonstrate the utility of the rat model in
the evaluation of cardiovascular and pulmonary responses to moderate decompression
stress. Changes in cardiovascular parameters are consistent with those reported in
other species such as the dog or the pig (7,17,58). MAP values are commonly in-
creased (often nonsignificant)with moderate decompression exposures in the larger
species. We observed an increase in MAP during compression only with no changes
post decompression. Decreases in HR have been reported during compression, while
increases lasting up to several hours post decompression or no change at all have also
been reported (7,58). In our study, the increase in HR observed 60 min. post decom-
pression was not significant. Changes in HR may be attributable to sympathetic stimu-
lation or changes in PaCO2while concomitant increases in system vascular resistance
may also be a result of direct sympathetic stimulation or a result of cathecholamine re-
lease (13,19).
Previous studies have reported a decrease in CO following an increase in pul-
monary vascular resistance (46). Others have suggested that decompression-induced
decreases in CO may be due to changes in venous return, increased load on the right
ventricle as a result of the obstructed pulmonary circulation or to increased afterload on
the left ventricle due to the elevated system vascular resistance (17,46,58).
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Our data suggest that a decrease in venous return may be responsible for the
decrease in CO recorded after decompression. Evidence supporting this concept in-
cludes:
1) The decrease in right thickening fraction (TF) related to either a decrease in an
intrinsic cardiac inotropism or a decrease in venous return. Both mechanisms
have been previously described. Right ventricular failure may occur because of
myocardial ischemia resulting from a decrease in coronary blood flow due to a
decrease in coronary perfusion pressure, (e.g., decrease in aortic diastolic pres-
sure associated with elevated right ventricular end-diastolic pressures) (36) or a
failure of the right ventricle to compensate for the increase in pulmonary vascular
resistance due to the presence of bubbles following decompression. However, it
is unlikely that a decompression-induced right ventricular failure was involved in
the decrease in TF. Thus, the TF decreased only in the right ventricle after de-
compression. Furthermore, the changes cited above are reported with more se-
vere cases of DCS or with air embolization where right ventricular pressures are
greatly increased.
2) In the absence of cardiac failure, a decrease in venous return is associated with
a decrease in preload of the left ventricle.
3) It is established that in the absence of preload changes, an increase in afterload
(e.g., systemic vasoconstriction) is associated with a compensatory increase in
cardiac contractility to maintain cardiac output. This is reflected as an increase in
left TF (Starling's Law).
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In our experimental conditions, left TF remained unchanged despite an increase
in systemic vascular resistance and decrease in CO. Therefore the lack of expected left
TF increase also represents an argument in favor of a decrease in venous return occur-
ring after decompression. Any additional effects of venous bubbles or mediator-induced
changes in venous resistance and/or capitance may also have contributed to a de-
crease in venous return.
Pulmonary effects of decompression-induced or exogenously introduced venous
bubbles include their interactions with cellular components of the blood. Such interac-
tions include platelet and neutrophil activation and the associated release of bioactive
mediators including; serotonin, histamine, kinins, prostaglandins, lymphokienes, throm-
boxanes and leukotrienes (16,24,50,59). These agents can alter microvascular mem-
brane and epithelial permeability and vascular tone, leading to pulmonary edema for-
mation (16). This was evident in the present study by an increase in EVLW as well as
increases in WBC's in BAL and pulmonary blood as well as neutrophil percentages in
pleural and BAL fluid. Ohkuda et al. (47) and others have demonstrated pulmonary
edema with venous air infusion suggesting a reversible change in permeability of the
microvascular membrane. Catron et al. (18) and Peterson et al. (49) reported pulmo-
nary edema after DCS or venous air infusion without an increase in left ventricular end-
diastolic pressures. These observations are consistent with the reported data and sug-
gest that even with moderate decompression, some change in lung fluid balance is pos-
sible. Similar changes have been reported with widely variable pressure exposures in
animals and man (7,16,18,32,33). The significant increases in lysophosphatidylcholine
are consistent with other studies suggesting its role in altering lung fluid balance, espe-
17
cially regarding changes in BAL (14). Venous air embolism in dogs has been shown to
cause pulmonary endothelial disruption, platelet and leukocyte adherence to bubble
surfaces and increases in leukocyte counts and degranulation (1,43). Similar findings
have been reported in mesenteric vessels after decompression in rats (50) and in pul-
monary vessels in mice (5)° The results of this study demonstrate cardiovascular func-
tion and pulmonary changes with moderate DCS in the rat. They further demonstrate
that the effects of circulating bubbles can be measured physiologically even in a small
animal model at moderate decompression exposures and parallel many of the reported
changes that are seen with larger animals and man.
I1. Tail-Suspension Studies
Previous reports describing cardiopulmonary responses to significant decom-
pression illness included hypotension, pulmonary hypertension, pulmonary edema, de-
creased lung compliance, hemoconcentration and hypoxemia (7,15,18,21,30). In simi-
lar conditions, Bove et al. observed increased systemic vascular resistance, tachycar-
dia, increased central venous pressure and decreased cardiac output (7). Cardiovas-
cular symptom expression and severity depend primarily on the extent of the decom-
pression injury and hence the degree of venous bubble formation. In our experimental
design, the use of a venous air dose standardized by weight, insured that the venous
gas insult was uniform throughout the study population. Our findings demonstrate an
attenuation in the response to both pulmonary edema formation and the decrease in
cardiac output with simulated weightlessness and venous embolization (TS-VAE group).
Several mechanisms may be involved in the response of the deconditioned car-
diopulmonary system to venous air embolizationo The changes in cardiac output may
be due to either fluid shifts or to a direct effect on myocardial function. The effects on
the lungs include vascular distension, changes in volume, changes in ventilation to
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perfusion matching and potential changes in diffusing capacity (55). Additional factors
may include mediator-induced changes in vascular tone and endothelial permeability
(54), lymphatic recruitment (57), as well as hypoxic pulmonary vasoconstriction.
In the present study, there was a slight but non-significant decrease in cardiac
output with tail suspension, a finding that in magnitude is consistent with other studies
(9). This change could be expected to prolong recovery from a venous gas insult, pos-
sibly by decreasing pulmonary blood flow and thereby reducing the rate of gas embolus
washout. However, venous air infusion produced an acute decrease in cardiac output
in all animals, whereas in the TS-VAE group, the decrease in cardiac output was signifi-
cantly less than the decrease experienced by the VAE alone group. It might therefore
be inferred that even though both groups demonstrated approximately the same total
decrease in cardiac output, the initial decrease experienced by the TS-VAE group oc-
curred prior to the VAE and therefore may have allowed for compensatory changes to
Occur.
The result of a higher cardiac output in the TS-VAE group (after first hour of air
infusion) relative to the VAE group may have allowed an increase in pulmonary perfu-
sion enabling deeper penetration of the emboli into the pulmonary vascular tree. The
emboli would thus block a smaller segment of the pulmonary vasculature and therefore
obstruct less of the pulmonary blood flow. This could result in a lower pulmonary artery
pressure and less edema formation. A higher cardiac output might also increase the
diffusion of gas from the emboli into the surrounding blood by exposing the emboli to a
greater volume of blood per unit time, resulting in a more rapid rate of resolution (42).
This process might also be influenced by accumulation of protein and coagulation prod-
ucts at the blood-bubble interface (50). Measurement of left ventricular myocardial wall
thickening fraction, an indicator of myocardial contractility, demonstrated no direct ef-
fects of either tail suspension or venous air emboli on the myocardium.
We observed that the systemic vascular resistance was increased initially in the
TS-VAE group, in response to tail-suspension, with no further increase during venous
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air embolization. An analogous response in the pulmonary circulation, especially when
venous bubbles obstruct pulmonary vessels, could result in a smaller increase in pul-
monary artery pressure with venous air embolization than would be expected, leading to
a decrease in pulmonary edema formation. Direct evidence for such a mechanism is
unavailable.
The decrease (nonsignificant) in HR with the VAE in both groups was consistent
with other reports of VAE or decompression in dogs (12,15). Possible mechanisms may
include a bundle branch block if the insult was sufficient to causes myocardial ischemia
(22) or a reflex-mediated response where the right heart chamber volumes are over-
whelmed due to the venous gas challenges (10). Both of these mechanisms are usu-
ally reported with large VAE doses, however, that are sufficient to cause systemic hy-
potension.
Simulated microgravity has been shown to improve ventilation to perfusion ratio
via central fluid shifts (26). This might improve tolerance to pulmonary air emboli by
both maximally recruiting the pulmonary vasculature and by optimizing the lung's ability
to exchange gas, thereby eliminating the gas via the alveoli. This too could result in a
decrease in pulmonary edema formation, as seen in our studies.
Indirect effects of venous air bubbles include neutrophil activation and mediator
release (16,54) resulting in modification of vascular permeability and tone with conse-
quent pulmonary edema formation. Evidence of this process was observed in all ani-
mals exposed to venous air infusion. Arterial, pleural and pulmonary arterial neutrophil
percentages were increased in both the TS-VAE and the VAE groups, but only the VAE
group showed significant changes in systemic arterial and pleural total white blood cell
count, suggesting a possible mechanism for increased mediator activation in the VAE
group as compared to the TS-VAE group. The decreased BAL and pleural protein val-
ues further suggest that the permeability of the microvascular and alveolar membranes
were less affected in the tail-suspension-VAE rats than the VAE alone.
2O
Conclusions drawn from the present study are subject to certain limitations. It
has been shown by other investigators that venous gas emboli will be distributed ac-
cording to the gravity vector. However, Chang et al. reported that the size of the bub-
ble, the speed of the blood flow and the size of the vessels do play a role. The authors
found that under most circumstances, the emboli followed the higher branch of a bifur-
cation (20). While the current model mimics the greater homogeneity in blood flow seen
in microgravity, one would still expect a preponderance of emboli in the "upper" lobes.
Additionally, the bubbles produced by venous air embolization are larger than DCS-
induced bubbles, consequently some differences in pulmonary arterial occlusion pat-
terns and possibly in surface-area dependent processes such as cellular activation and
lung fluid balance might be expected. Although the results of the present study reflect
some cardiopulmonary changes, clinical symptoms of DCS involving limb pain are usu-
ally attributed to extravascular gas.
Several theories have been reported to explain the observed low incidence of
hypobaric decompression illness during EVA. A decrease in the formation of micronu-
clei due to reduced stress on the muscles, tendons and ligaments of the joints as a con-
sequence of reduced activity (exposure) in the microgravity environment has been de-
scribed (52). Additional reasons may involve actual reporting discrepancies related to
operational factors such as crew motivation, redirected attention, masking of subtle
pain, misinterpreting actual symptoms or actual reluctance to report DCS (4). The re-
sults of the present study do suggest however, that more than one process may be re-
sponsible for the decreased incidence of DCS (at least in terms of cardiopulmonary ef-
fects), including an overall increase in tolerance to the combined effects of simulated
microgravity and decompression.
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Table 1: Lung Function and Blood Gas Data
Compliance (ml/cmH20)
TLC (ml)
PaO2 (mmHg)
PaCO2 (mmHg)
PH
CONTROL
1.10_+ 0.02 (4)
22.1 +_0.04 (5)
91.8 +_3.53 (20)
44.9 + 2.35 (23)
7.36 +0.016 (23)
POST DECOMPRESSION
(0 min)
1.00 +_0.o5 (5)
21.6 + 1.14 (6)
81.2 _+4.34 (25)
51.0"+ 1.77 (26)
7.32 +0.012 (26)
(60 rain)
0.92 +_0.06 (9)
20.8 + 0.56 (9)
101.2" _4_-2.30 (35)
42.6 +__1.31(35)
7.37 _+0.012 (35)
Data are Mean SE. Numbers in brackets are n.
*p < 0.05 vs. controls.
TLC = Total lung capacity (see Methods).
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Table 2: BAL Hb, BAL / Plasma Protein, EVLW Ratio, Phospholipids
BAL Hb (mill00 ml)
Plasma Protein (g/100 ml)
BAL Protein (g/100 ml) x 10 .3
BAL Protein/Plasma Protein
EVLW
Phosphotidylcholine (mg/gm lung)
Tissue
BAL
Lysophosphatidylcholine (mg/gm lung)
Tissue
BAL
CONTROL
0.02 _ 0.014 11)
4.83 _+0.20 (13)
12.87 _+1.20 (15)
2.67 +_0.26 (13)
4.18 + 0.05 (18)
3094 _+551 (7)
750_+ 101 (11)
364 _+36 (7)
2.0 + 0.4 (10)
POST DECOMPRESSION
(0 min) (60 min)
0.167 _+0.097 (11)
5.03 + 0.23 (14)
17.45 _+2.60 (15)
3.49 + 0.53 (14)
4.27 _+0.08 (22)
0.375*+0.077 (12)
5.22 + 0.11 (14)
22.81"+_2.22 (16)
4A0"-+0.58 (14)
4.53*_+0.13 (24)
4218 + 605 (12)
668 -+85 (10)
4478 + 747 (12)
745 -+ 104 (11 )
408 -+36 (12)
4.2* -+0.8 (10)
356 +_18 (11)
7.4*_+ 1.3 (9)
Data are mean + SE. Numbers in brackets are n.
EVLW = extravasular lung water ratio.
* p < 0.05 vs. controls.
BAL = bronchoalveolar lavage,
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TABLE 3. Lung edema, compliance and blood gas data
CONTROL T8 MAE TS-VAE
EVLW 4.18+0.21 3.80___0.41 6.02+0.68"§ 4.78+0.73"
Compliance 2.20+0.22 2.10_+0.21 2.00_+0.08 1.90+0.17
PaO2(mmHg) 89.90_+5.18 91.00_+8.83 77.20_+7.78 75.70_+16.86
PaCO2(mmHg) 44.90_+2.35 50.30+3.75 47.20_+2.33 47.50_+5.80
pH 7.35_+0.02 7.25_+0.02 7.24_+0.04 7.27_+0.03
Dataare representedas mean_+S.D.
*p<0,05comparedwithcontrol
p<0.05 comparedwithTS-VAE
EVLW= extravascularlungwater ratio
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TABLE 4: Cell counts and protein data
Total WBC
(cells/mm 3)
Arterial
Pulmonary
BAL
Pleural
CONTROL TS VAE
7920±386
7970±427
674±53
54462±5050
7831±838
8903±1074
371±61
60133±9019
7975±1448
.
13139±1242
638±141
20539±3005
TS-VAE
6066±1051
10457±1840
880±185
46169±10354
Neutrophils
(percentage of total WBC)
Arterial 4.90±1.34 29.60±6.34 70.10±2.99" 68.10±6.28"
Pulmonary 1.27±0.96 24.10±5.17 55.10±4.38" 52.95±31"
BAL 0.68±0.19 2.60±1.66 3.20±1.52 2.30±0.75
Pleural 1.63±0.24 4.60±0.54" 11.40±0.32" 10.60±1.09"
Protein
(mg/dl)
Plasma 48.30±2.09 51.92±1.66 50.45±2.33 49.15±2.85
BAL 7.08±0.60 55.00±0.50 20.06±4.92 14.91±8.72
Pleural 18.64±1.14 16.25±1.27 27.68±0.97" 13.77±2.81
WBC = white blood cells
Data are represented as mean ± S.D.
• p<0.05 compared with control
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FIGURE LEGENDS
FIGURE 1:
Top; White blood cell count; percentage of neutrophils in three groups. Signifi-
cant increase in percentages were observed in the bronchoalveolar lavage (BAL)
and pleural fluids, 60 min. post decompression.
Bottom; White blood cell counts. Significant increases were observed in the
bronchoalveolar lavage (BAL) at 0 min. and 60 min. post decompression and in
pulmonary blood 60 min post decompression. Pleural WBC counts were de-
creased 0 min, returning to control values 60 min post decompression.
FIGURE 2:
Mean arterial blood pressure (MAP) and systemic vascular resistance (SVR)
changes with decompression. MAP increased at depth while SVR increased
immediately upon surface and 60 min. post decompression.
FIGURE 3:
Cardiac output (CO) decreased at surface and 60 min. post decompression while
right ventricular thickening fraction (TFRv) showed parallel responses.
FIGURE 4:
Systemic vascular resistance (SVR) and cardiac output (CO) are plotted as per-
cent change from baseline over time for the TS-VAE and VAE groups. Venous
air infusion started at Time = 0 and continued until Time = 3 hrs. TS-VAE SVR
values were significantly elevated from the onset of tail-suspension and through-
out the air infusion. SVR was also elevated in the VAE group during the air infu-
sion and for 2 hrs. recovery. Cardiac output was decreased significantly from
baseline during the air infusion in both groups, and significantly different from
each other at 180 min. infusion.
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FIGURE 5:
Heart rate (HR) and mean arterial pressure (MAP) are plotted as a function of
time. Venous air infusion started at Time = 0 and continued until Time = 3 hrs.
MAP values were not significantly changed. HR decreased significantly in both
groups during the air infusion.
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